BridgeMD
New treatment option for Nursing Home Residents
Official title Improved Prescribing for Older Nursing Home Patients
ClinicalTrials.gov ID: NCT06731361
What this study is testing
What is Systematic multidisciplinary medication review + ACP (SMMR+)?
Systematic multidisciplinary medication review + ACP (SMMR+) is an investigational medicine, being studied as a potential treatment for nursing home residents.
Also referred to as ReNeWAL criteria, Pocket card.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Research aim: To investigate the effect of training health care professionals in medication assessments on the medication use of nursing home residents with a limited life expectancy (\< 1.5-2 years). The core of the training is to tailor medication use to (palliative) treatment goals of nursing home residents.
- Time commitment: about 1 year
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Nursing home patients:
- Age 65years and above
- Living at long term care wards in nursing homes
- Living at a long term care ward for at least 4 weeks before start of the study
You likely can't join if
- Temporary nursing home patients (i.e. geriatric rehabilitation or end-of-life/hospice care)
- Life expectancy \< 4 weeks
- Life expectancy clearly \> 1.5 - 2 years (i.e. patients with Huntingtons disease)
The study team makes the final eligibility decision.
Where it's taking place
- Apeldoorn, Gelderland, Netherlands
- Harderwijk, Gelderland, Netherlands
- Amsterdam, North Holland, Netherlands
- Hilversum, North Holland, Netherlands
- IJsselstein, Utrecht, Netherlands
- Vianen, Utrecht, Netherlands
- Groningen, Netherlands
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 1 year per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Apeldoorn, Gelderland, Netherlands; Harderwijk, Gelderland, Netherlands; Amsterdam, North Holland, Netherlands; Hilversum, North Holland, Netherlands; IJsselstein, Utrecht, Netherlands; Vianen, Utrecht, Netherlands and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.